BAK News and Press, Braskem SA ADR From 11/11/25

2025-11-11 18:41:32 ET Braskem S.A. (BAK) Q3 2025 Earnings Call November 11, 2025 10:30 AM EST Company Participants Rosana Avolio - Investor Relations Manager Roberto Ramos - Chief Executive Officer Felipe Montoro Jens - Chief Financial & Investor Relations Off...

2025-11-11 11:57:52 ET More on Braskem Braskem: Novonor To The Rescue (Rating Upgrade) Braskem Q2 2025 Earnings Call Presentation Seeking Alpha’s Quant Rating on Braskem Read the full article on Seeking Alpha For further details see: Braske...

2025-11-11 10:53:55 ET More on Braskem S.A. Braskem: Novonor To The Rescue (Rating Upgrade) Braskem S.A. 2025 Q2 - Results - Earnings Call Presentation Braskem approves $780M expansion of Rio de Janiero plant to boost ethylene production Braskem plunges as Ci...

2025-11-10 10:00:00 ET Major earnings expected after the bell on Monday include: Plug Power ( PLUG ) Occidental Petroleum Corporation ( OXY ) Beyond Meat ( BYND ) Inovio Pharmaceuticals ( INO ) BigBear.ai Holdings ( BBAI ) Read the full arti...

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

2025-10-27 10:54:57 ET More on Braskem Braskem: Novonor To The Rescue (Rating Upgrade) Braskem: On The Edge Braskem Q2 2025 Earnings Call Presentation Read the full article on Seeking Alpha For further details see: Braskem approves $780M expansion...

Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK), the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale, and Balsam Hill ®, the global leader in high-quality, true-to-nature, reusable artificial Christmas...

2025-10-21 02:22:05 ET Introduction Read the full article on Seeking Alpha For further details see: Braskem: Novonor To The Rescue (Rating Upgrade)

2025-10-16 01:15:03 ET Santander analyst issues UNDERPERFORM recommendation for BAK on October 16, 2025 12:09AM ET. The previous analyst recommendation was Neutral. BAK was trading at $2.54 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Braskem S.A. (“Braskem” or “the Company”) (NYSE: BAK ) for violations of the securities laws. The investigation focuses on...